Published in Lab Law Weekly, June 10th, 2005
This patent allows GenVault to offer and license GenCode, its DNA labeling technology, to a broader market and positions it as the only company to offer double labeling for nucleic acid samples. This technology makes it possible for scientists to identify the sample through its complete downstream analysis to maintain a permanent chain of custody.
"Acquiring this patent is a valuable acquisition for GenVault...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly